Updated:
CTK
CTK began in 2001 under founder Chung In Yong as an operator of a cosmetics platform. The firm provides R&D, marketing, production, and logistics services from...
CTK
CTK began in 2001 under founder Chung In Yong as an operator of a cosmetics platform. The firm provides R&D, marketing, production, and logistics services from its Seoul base. Chung In Yong continues as President while Cheeho Choi serves as CEO. CTK allocates capital into buyouts and venture stages including seed and start-up rounds. It has executed investments across multiple geographies with activity noted in North America and Asia. The firm sold its electronics testing division to Element Materials Technology Group Limited in August 2023. Confirmed holdings remain limited in public records. The firm lists 149.58 million USD in assets under an internal estimate. It operates additional sites including CTK OTC LABORATORIES in Corona, California. No philanthropic vehicles or club memberships appear in available records. CTK integrates investment decisions with its operating platform rather than maintaining a standalone allocation team.
General information
Firm type
Corporate Investor
Year founded
2001
AUM
150 (Altss estimate)
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Principals
Chung In Yong
Founder and President
Cheeho Choi
CEO
Sector focus
Frequently asked questions
Who runs investment decisions at CTK?
Chung In Yong serves as Founder and President. Cheeho Choi holds the CEO title and leads U.S. OTC operations.
Is CTK structured as a single family office or does it operate more like a venture firm?
CTK functions as a corporate investor tied to its cosmetics platform. It does not present as a family office.
What investment stages does CTK typically target?
The firm targets buyout, early stage seed, start-up, and expansion rounds according to internal records.
Where does the underlying wealth come from?
No public disclosure links CTK to a specific family fortune. Capital appears generated through the cosmetics platform operations.
Does CTK participate in fund commitments or only direct deals?
Available information shows direct activity through its platform without named fund commitments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: